Adma Biologics Inc (ADMA)

Operating Cash Flow (Statement)

$136.72M

TTM · Period ending: · USD

ADMA logo

ADMA Operating Cash Flow (Statement)

Latest reported$136.72M
ADMA TTM Cash from Operations (-$17.25M → $136.72M)
High-resolution chart · PNG

ADMA operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Adma Biologics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
136,720,000
128,320,000
50,396,000
64,973,000
76,708,000
101,215,000
118,672,000
86,051,952
73,008,952
21,304,196
8,799,196
-16,176,071
-41,445,832
-48,217,844
-59,508,257
-85,594,174
-85,721,800
-105,153,269
-112,368,982
-111,123,186
-121,562,886
-110,585,124
-102,002,958
-89,435,558
-89,213,803
-86,553,280
-76,193,504
-75,334,592
-64,247,665
-60,531,752
-62,678,682
-57,244,187
-54,440,153
-48,307,462
-37,271,774
-27,526,823
-22,470,640
-18,499,469
-18,268,973
-18,733,504
-16,723,369
-16,365,559
-15,418,404
-14,242,628
-14,035,443
-13,885,355
-14,704,910
-14,762,240
-14,522,034
-12,852,713
-10,887,154
-9,734,441
-9,609,967
-7,979,867
-6,903,795
-5,109,575
-3,013,570
-2,024,392
-29,601
-25,790
-29,000
-23,242
-23,244
-8,440,225
-13,849,832
-18,267,910
-22,684,000
-10,872,000
-9,376,000
-7,174,000
-8,772,000
-19,005,000
-17,094,000
-17,246,000
-15,948,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.